Hong Kong scientists develop COVID-19 vaccine nasal spray - ForumDaily
The article has been automatically translated into English by Google Translate from Russian and has not been edited.
Переклад цього матеріалу українською мовою з російської було автоматично здійснено сервісом Google Translate, без подальшого редагування тексту.
Bu məqalə Google Translate servisi vasitəsi ilə avtomatik olaraq rus dilindən azərbaycan dilinə tərcümə olunmuşdur. Bundan sonra mətn redaktə edilməmişdir.

Hong Kong Scientists Develop COVID-19 Vaccine Nasal Spray

Scientists from the University of Hong Kong have completed work on a special nasal spray containing a vaccine for both common flu and COVID-19: it will begin human trials next month, writes "Ukrinform".

Photo: Shutterstock

The essence of this project is to destroy viruses, in particular COVID-19, right in the nose, from where they usually enter the human body.

If immunization against influenza using nasal sprays is already known, then the new drug, as the development scientists hope, should also provide protection against coronavirus.

Through trials on hamsters, Chinese scientists in Hong Kong have found that certain drugs used to treat infectious diseases are effective in suppressing COVID-19 symptoms.

Initially, it is planned to attract about 100 people for clinical trials of the spray vaccine. During the testing, Chinese scientists will investigate, in particular, the safety of the vaccine, as well as the optimal dose for each person. Scientists have already filed a US patent for the manufacture of such a vaccine.

As you know, not a single effective vaccine against coronavirus is ready yet, although a number of states say they are working on their own vaccines against COVID-19. But all this is still only at the stage of clinical trials.

On the subject: A vaccine that partially protects against COVID-19 already exists

The only vaccines registered in the world so far are the Russian Sputnik V or Gam-Covid-Vac and EpiVacCorona. The first drug was developed by the National Research Center for Epidemiology and Microbiology named after. N.F. Gamaleya, the second - Novosibirsk State Scientific Center of Virology and Biotechnology "Vector". At the same time, the third phase of clinical trials has not been completed for these vaccines. At the same time, there is an international norm that a vaccine can be registered and widely used only after the successful completion of three phases of clinical trials.

According to WHO, so far only 10 vaccines are in the third stage of testing - randomized, double-blind trials among a large number of volunteers. At this stage, test participants are given not only the vaccine, but also a placebo, and neither they nor the doctors know who gets what.

Read also on ForumDaily:

'For security reasons': two companies at once suspended trials of drugs for COVID-19

Accidental, risky and unethical: how the world's first vaccine was invented

A vaccine that partially protects against COVID-19 already exists

'Not everyone knows why they came': how the Russian vaccine against COVID-19 is tested in humans

Fever and severe headache: COVID-19 vaccine test subjects report their well-being

Miscellanea vaccine World coronavirus Special Projects
Subscribe to ForumDaily on Google News

Do you want more important and interesting news about life in the USA and immigration to America? — support us donate! Also subscribe to our page Facebook. Select the “Priority in display” option and read us first. Also, don't forget to subscribe to our РєР ° РЅР ° Р »РІ Telegram  and Instagram- there is a lot of interesting things there. And join thousands of readers ForumDaily New York — there you will find a lot of interesting and positive information about life in the metropolis. 



 
1078 requests in 1,212 seconds.